These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24742479)

  • 1. Association of a polymorphism in a gene encoding a urate transporter with CKD progression.
    Testa A; Mallamaci F; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Leonardis D; Zoccali C
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1059-65. PubMed ID: 24742479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.
    Testa A; Mallamaci F; Leonardis D; Spoto B; Pisano A; Sanguedolce MC; Tripepi G; Zoccali C;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):167-72. PubMed ID: 25435339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.
    Testa A; Prudente S; Leonardis D; Spoto B; Sanguedolce MC; Parlongo RM; Tripepi G; Rizza S; Mallamaci F; Federici M; Trischitta V; Zoccali C
    Nutr Metab Cardiovasc Dis; 2015 Dec; 25(12):1087-94. PubMed ID: 26607700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study.
    Mallamaci F; Testa A; Leonardis D; Tripepi R; Pisano A; Spoto B; Sanguedolce MC; Parlongo RM; Tripepi G; Zoccali C
    J Hypertens; 2014 Aug; 32(8):1621-8; discussion 1628. PubMed ID: 24805955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study.
    Mallamaci F; Testa A; Leonardis D; Tripepi R; Pisano A; Spoto B; Sanguedolce MC; Parlongo RM; Tripepi G; Zoccali C
    Am J Kidney Dis; 2015 Feb; 65(2):294-302. PubMed ID: 25301104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women.
    Liu J; Zhang H; Dong Z; Zhou J; Ma Y; Li Y; Qian Q; Yuan Z; Zhang J; Yang Y; Wang X; Chen X; Zou H; Jin L; Wang J
    Int Urol Nephrol; 2017 Nov; 49(11):2035-2042. PubMed ID: 28856502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.
    Stark K; Reinhard W; Grassl M; Erdmann J; Schunkert H; Illig T; Hengstenberg C
    PLoS One; 2009 Nov; 4(11):e7729. PubMed ID: 19890391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study.
    Ueda M; Fukui K; Kamatani N; Kamitsuji S; Matsuo A; Sasase T; Nishiu J; Matsushita M
    J Hum Genet; 2023 Oct; 68(10):699-704. PubMed ID: 37308567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
    Stark K; Reinhard W; Neureuther K; Wiedmann S; Sedlacek K; Baessler A; Fischer M; Weber S; Kaess B; Erdmann J; Schunkert H; Hengstenberg C
    PLoS One; 2008 Apr; 3(4):e1948. PubMed ID: 18398472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
    Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.
    McKeigue PM; Campbell H; Wild S; Vitart V; Hayward C; Rudan I; Wright AF; Wilson JF
    Int J Epidemiol; 2010 Jun; 39(3):907-18. PubMed ID: 20348110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of an intronic SNP of SLC2A9 gene with serum uric acid levels in the Chinese male Han population by high-resolution melting method.
    Guan M; Zhou D; Ma W; Chen Y; Zhang J; Zou H
    Clin Rheumatol; 2011 Jan; 30(1):29-35. PubMed ID: 20972595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.